Herbicidal mixtures comprising l-glufosinate and their use in corn cultures
US-2024407367-A1 · Dec 12, 2024 · US
US2024284904A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024284904-A1 |
| Application number | US-202218563694-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 28, 2022 |
| Priority date | Oct 21, 2021 |
| Publication date | Aug 29, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
An antibacterial composition including a compound represented by the disclosed formula 1 and having an antibacterial activity of 80% or more as measured by the disclosed method 1, against at least one strain of gram-positive bacteria, gram-negative bacteria, and fungus. Since the antibacterial composition includes a hydrophilic functional group and a hydrophobic functional group at the same time, it is advantageous for imparting antibacterial properties.
Opening claim text (preview).
1 . An antibacterial composition including one or more compounds represented by formula 1 below and having an antibacterial activity of 80% or more, as measured by method 1 below, against at least one strain of gram-positive bacteria, gram-negative bacteria, and fungus: wherein, L1 and L2 are the same as or different from each other, and are each independently a direct bonds a substituted or unsubstituted alkylene group having 1 to 4 carbon atoms, or a substituted or unsubstituted arylene group having 6 to 30 carbon atoms; A is hydrogen, or a substituted or unsubstituted alkyl group having 1 to 3 carbon atoms-; n is an integer of 0 to 4; R1 and R2 are the same as or different from each other, and each independently a substituted or unsubstituted alkyl group having 1 to 20 carbon atoms, and at least one of R1 and R2 is a substituted or unsubstituted alkyl group having 1 to 10 carbon atoms; and R3 is an alkyl group having 4 to 20 carbon atoms, wherein when n is 2 or more, As having n of 2 or more are the same as or different from each other; and [Method 1] after putting 25 mL of a broth-type medium inoculated with 3,000 CFU/mL of bacteria in a 50 mL conical tube, 0.015 g of the antibacterial composition i added and suspended, and a sufficiently mixed solution is cultured for 16 hours in a shaking water bath maintained at 35° C., and after diluting the cultured solution to 1/5 using 1×PBS buffer solution, an absorbance is measured using a UV/Vis spectrophotometer, and the measured absorbance is compared with the solution cultured without addition of the antibacterial composition to calculate the antibacterial activity, which is a bacteriostatic reduction rate, by an equation as follows: Antibacterial activity ( % ) = ( 1 - A sample / A Reference ) × 100 A sample = Absorbance of medium solution cultured with addition of antibacterial composition A Reference = Absorbance of medium solution cultured without addition of antibacterial composition 2 . The antibacterial composition of claim 1 , wherein the antibacterial activity is 90% or more. 3 . The antibacterial composition of claim 1 , wherein the gram-positive bacteria are any one selected from Enterococcus faecalis, Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogene, Enterococcus faecium , and Lactobacillus lactis. 4 . The antibacterial composition of claim 1 , wherein the gram-negative bacteria are any one selected from Proteus mirabilis, Escherichia coli, Salmonella typhi, Pseudomonas aeruginosa, Vibrio cholerae , and Enterobacter cloacae. 5 . The antibacterial composition of claim 1 , wherein at least one of the R1 and R2 is an unsubstituted alkyl group having 1 to 4 carbon atoms. 6 . The antibacterial composition of claim 1 , wherein the R3 is an unsubstituted alkyl group having 4 to 16 carbon atoms. 7 . The antibacterial composition of claim 1 , wherein, when the R1 and R2 are the same as or different from each other and each independently a methyl group or an ethyl group, the R3 is an alkyl group having 4 to 16 carbon atoms. 8 . The antibacterial composition of claim 1 , wherein the L1 is a direct bond. 9 . The antibacterial composition of claim 1 , wherein the L2 is a methylene group. 10 . The antibacterial composition of claim 1 , wherein the compound represented by formula 1 above is any one selected from the group consisting of structures as follows:
Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change · CPC title
Amines · CPC title
Homopolymers or copolymers of aromatic monomers containing elements other than carbon and hydrogen · CPC title
Amines · CPC title
Fungicides · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.